Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC

Tan, AC; Seet, AOL; Lai, GGY; Lim, TH; Lim, AST; Tan, GS; Takano, A; Tai, DWM; Tan, TJY; Lam, JYC; Ng, MCH; Tan, WL; Ang, MK; Kanesvaran, R; Ng, QS; Jain, A; Rajasekaran, T; Lim, WT; Tan, EH; Lim, TKH; Tan, DSW

Tan, DSW (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Crescent, Singapore 169610, Singapore.

JOURNAL OF THORACIC ONCOLOGY, 2020; 15 (12): 1928

Abstract

Introduction: RET rearrangements are an emerging targetable oncogenic fusion driver in NSCLC. However, the natural history of disease and activity of ......

Full Text Link